Diabetes Population Health Management

Presented By:
Dr. Ronald Harris
Population Health Management Consultant

With the epidemic of obesity, aging population, burgeoning health care disparities and steady growth in health care related spending, diabetes represents a chronic disease affecting over 30 million Americans. As diabetes continues to effect larger portions of the US and global populations, effective health care approaches that address diabetes at the population level are urgently needed.
This PHA webinar will discuss how a population based care can be applied to the management of diabetes. Attendees of this unique educational offering will:

  • learn how to address the growing prevalence of diabetes and the financial impact it has on the United States health care landscape
  • understand the elements of success in implementation of population health management for patients with diabetes
  • see examples of how population based care can be applied to the management of diabetes

About the Presenter:

Dr. Harris has 40 years of clinical experience and a tireless passion for the study of endocrinology and, in particular, diabetes. He served as Clinical Program Director, Diabetes, Geisinger Health Plan where he was responsible for setting the quality agenda for diabetes. This led to the first application for multi-site recognition for over 450 primary care physicians for NCQA’s Diabetes Provider Recognition Program. Nationally, he has served on NCQA’s Diabetes Provider Recognition Committee, Performance Measurement Committee, Clinical Program Committee. He previously served as a member of the Endocrine Society’s Quality Improvement as well as Health Care Delivery System Sub-Committees and representative to CMS’s Macra Episode-Based Resource Use Measures- Clinical Committee.

His research has involved motivational interviewing and medication adherence in high risk patients with diabetes, longitudinal cohorts and comparative effectiveness research utilizing rich data in electronic health records, genetics of latent autoimmune diabetes, novel drugs in the treatment of diabetes and e-Diabetes integrating shared decision making with patient preferences.

He received his medical degree from Tulane University School of Medicine, internal medicine internship Philadelphia General Hospital University of Pennsylvania, residency Boston VA, Jamaica Plains. He completed his endocrinology fellowship at the University of Pennsylvania.

July 27, 2020

Presented By:
Dr. Ronald Harris
Population Health Management Consultant

With the epidemic of obesity, aging population, burgeoning health care disparities and steady growth in health care related spending, diabetes represents a chronic disease affecting over 30 million Americans. As diabetes continues to effect larger portions of the US and global populations, effective health care approaches that address diabetes at the population level are urgently needed.
This PHA webinar will discuss how a population based care can be applied to the management of diabetes. Attendees of this unique educational offering will:

About the Presenter:

Dr. Harris has 40 years of clinical experience and a tireless passion for the study of endocrinology and, in particular, diabetes. He served as Clinical Program Director, Diabetes, Geisinger Health Plan where he was responsible for setting the quality agenda for diabetes. This led to the first application for multi-site recognition for over 450 primary care physicians for NCQA’s Diabetes Provider Recognition Program. Nationally, he has served on NCQA’s Diabetes Provider Recognition Committee, Performance Measurement Committee, Clinical Program Committee. He previously served as a member of the Endocrine Society’s Quality Improvement as well as Health Care Delivery System Sub-Committees and representative to CMS’s Macra Episode-Based Resource Use Measures- Clinical Committee.

His research has involved motivational interviewing and medication adherence in high risk patients with diabetes, longitudinal cohorts and comparative effectiveness research utilizing rich data in electronic health records, genetics of latent autoimmune diabetes, novel drugs in the treatment of diabetes and e-Diabetes integrating shared decision making with patient preferences.

He received his medical degree from Tulane University School of Medicine, internal medicine internship Philadelphia General Hospital University of Pennsylvania, residency Boston VA, Jamaica Plains. He completed his endocrinology fellowship at the University of Pennsylvania.